Saturday, September 25, 2021 4:39:19 PM
Future co-operation about scientific decisions and better planning with the existing DMT stroke path and the Ifenprodil Cancer, CC/ARDS, stroke paths will benefit from an Involved Dr MW. Shareholders really took the beatings from this lack of involvement/decision making.
Dr MW / NASH were well compensated at the initiation of AGN, at the expense of BTH shareholders.
I hope all have learned from the difficulties of the company's efforts.
Dr MW may earn the CEO job through future efforts or/and connections. But, I see him as a 'brain guy' and not a 'sharp pencil' guy.
We will need partnerships to reduce dilution. We need the Skills of All AND some better Luck. I think the whole group realize the NEED to show some success for shareholders...I Hope...
Novotec has been a huge disappointment recruiting the IPF CT. Wish in one hand and reality in the other...GLTA...
FEATURED Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • May 16, 2024 8:13 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM
HealthLynked Corp Announces First Quarter 2024 Results: Achieves 8% Revenue Growth Over Last Quarter • HLYK • May 16, 2024 8:00 AM
Integrated Ventures Files Q3/2024 With Mining Revenues Of $1,983,250 And Positive Earnings Of $0.05 Cents Per Share • INTV • May 15, 2024 10:30 AM
Swifty Global Announces Impressive Financial Results for Q1 2024 • DRCR • May 15, 2024 10:25 AM